Kristin D Gerson1, Samantha Truong2, Miriam J Haviland3, Barbara M O'Brien3, Michele R Hacker3, Melissa H Spiel4. 1. Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, United States; Department Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA, United States; Maternal and Child Health Research Center, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States. 2. Harvard Medical School, Boston, MA, United States. 3. Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, United States; Department Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA, United States. 4. Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, United States; Department Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA, United States. Electronic address: mspiel@bidmc.harvard.edu.
Abstract
OBJECTIVE: To examine the association of low fetal fraction of cell-free DNA (cfDNA) with placental compromise and adverse perinatal outcomes. MATERIALS AND METHODS: This was a retrospective cohort utilizing a sample of convenience including 639 women undergoing cfDNA screening at our institution from January 2013 to January 2017. Low fetal fraction was defined as less than the 25th percentile. Indicators of placental compromise were examined individually and as a composite outcome, including hypertensive disease of pregnancy, intrauterine growth restriction, abruption, and oligohydramnios. Neonatal outcomes, including preterm delivery, low Apgar scores, and small for gestational age, also were examined. We calculated risk ratios (RR) and 95% confidence intervals (CI). RESULTS: Low fetal fraction was associated with placental compromise (RR 1.6 [CI 1.1-2.2]), hypertensive disease of pregnancy (RR 1.6 [CI 1.003-2.6]), and preeclampsia with severe features (RR 3.3 [CI 1.2-8.9]). Low fetal faction was not associated with preterm delivery, low Apgar scores, or small for gestational age. CONCLUSIONS: Low fetal fraction of cfDNA among asymptomatic women may serve as a predictor of subsequent placental dysfunction and hypertensive disease.
OBJECTIVE: To examine the association of low fetal fraction of cell-free DNA (cfDNA) with placental compromise and adverse perinatal outcomes. MATERIALS AND METHODS: This was a retrospective cohort utilizing a sample of convenience including 639 women undergoing cfDNA screening at our institution from January 2013 to January 2017. Low fetal fraction was defined as less than the 25th percentile. Indicators of placental compromise were examined individually and as a composite outcome, including hypertensive disease of pregnancy, intrauterine growth restriction, abruption, and oligohydramnios. Neonatal outcomes, including preterm delivery, low Apgar scores, and small for gestational age, also were examined. We calculated risk ratios (RR) and 95% confidence intervals (CI). RESULTS: Low fetal fraction was associated with placental compromise (RR 1.6 [CI 1.1-2.2]), hypertensive disease of pregnancy (RR 1.6 [CI 1.003-2.6]), and preeclampsia with severe features (RR 3.3 [CI 1.2-8.9]). Low fetal faction was not associated with preterm delivery, low Apgar scores, or small for gestational age. CONCLUSIONS: Low fetal fraction of cfDNA among asymptomatic women may serve as a predictor of subsequent placental dysfunction and hypertensive disease.
Authors: Jaime L Lopes; Guilherme S Lopes; Elizabeth A L Enninga; Hutton M Kearney; Nicole L Hoppman; Ross A Rowsey Journal: Prenat Diagn Date: 2020-04-20 Impact factor: 3.050
Authors: Ellis C Becking; Soetinah A M Wirjosoekarto; Peter G Scheffer; Julia V M Huiskes; Marinka J Remmelink; Erik A Sistermans; Caroline J Bax; Janneke M Weiss; Lidewij Henneman; Mireille N Bekker Journal: Prenat Diagn Date: 2021-09-09 Impact factor: 3.242
Authors: Raj Shree; Teodora R Kolarova; Hayley J MacKinnon; Jaclynne M Hedge; Elena Vinopal; Kimberly K Ma; Christina M Lockwood; Suchitra Chandrasekaran Journal: Prenat Diagn Date: 2021-08-14 Impact factor: 3.242
Authors: Peter G Scheffer; Soetinah A M Wirjosoekarto; Ellis C Becking; Marjan M Weiss; Caroline J Bax; Dick Oepkes; Erik A Sistermans; Lidewij Henneman; Mireille N Bekker Journal: Prenat Diagn Date: 2021-08-18 Impact factor: 3.242